BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 16, 2024
See today's BioWorld
Home
» News from ID Week 2017
To read the full story,
subscribe
or
sign in
.
News from ID Week 2017
Oct. 5, 2017
No Comments
Novoclem Therapeutics Inc., of Durham, N.C., reported data from an in vitro study with BIOC-51, a nitric oxide-releasing biopolymer in development for Pseudomonas aeruginosa infections in cystic fibrosis patients.
BioWorld